close
Leaving Sabril.net

You are about to leave the Sabril (vigabatrin) website and enter a website operated by an independent third party. The links to third-party websites contained on Sabril.net are provided solely for your convenience. Lundbeck does not control the opinions, claims, or comments contained on any third-party website linked to Sabril.net, and your activities at those websites will be governed by the policies and practices of those third parties.

Click "OK" to proceed to this third-party website or "Cancel" to stay at Sabril.net.

OK CANCEL
close
Leaving Sabril.net

The information contained in this section of Sabril.net is intended for U.S. healthcare providers only. If you are not a U.S. healthcare provider, and would like to return to the patient/caregiver section of the site, please click the "Return" button below.

Yes, I am a U.S. Healthcare Provider and would like to continue.


 

Sabril

Sabril is a good fit for me.

Unsubscribe

To unsubscribe from future updates, please enter your email address here.

Email address:

The product information provided in this site is intended only for residents of the U.S. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. Sabril may not be a fit for everyone. You and your doctor should decide if the possible benefits of taking Sabril are more important than the risk of permanent vision loss.

Note: All patients shown on this website were taking Sabril when they were photographed and/or videotaped.